Skip to content

Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test

Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-occlusive Patch)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01892657
Enrollment
128
Registered
2013-07-04
Start date
2008-03-31
Completion date
2008-08-31
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Irritation

Keywords

Cetaphil Daily Facial Moisturizer with SPF 50+, Hypoallergenicity, Skin Irritation

Brief summary

This study examined the possible sensitization and irritation effects of a moisturizer with sunscreen SPF 50+.

Detailed description

The design for this study is standard for human repeat insult patch tests. To test the moisturizer with sunscreen SPF 50+ for the potential to induce contact sensitization by repetitive applications, healthy subjects received 9 applications at 48 to 72 hour intervals of the moisturizer to the upper back. Patches were remained on the skin for approximately 48 to 72 hours. Twelve to 24 days after the previous applications, subjects were patched with the moisturizer at the original site and an alternative site for 48 hours.

Interventions

DRUGFacial Moisturizer with SPF 50+

All subjects received applications of occlusive patches dosed with Cetaphil Daily Facial Moisturizer with SPF 50+

Sponsors

Galderma R&D
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Men or women 18 to 70 years of age in general good health * Can read, understand, and sign informed consent

Exclusion criteria

* History of acute or chronic disease * Diagnosed with chronic skin allergies * Pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Area of Erythema and Elevated Responses of Skin to Product3 consecutive weeksSubjects were patched 9 times at 48 hour to 72 hour intervals and graded for erythema and elevated responses (edema, papules, vesicles, bullae) on a 4 point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). 12 to 24 hours after the last patch application, a challenge patch was applied at the same site and a challenge patch was applied to an alternate site. Both were graded for the same criteria at 48 hours and at 96 hours. A total of 11 patches were applied to each subject. All patches were removed after 48 hours.

Countries

United States

Participant flow

Recruitment details

Subjects were screened at a single US center.

Participants by arm

ArmCount
Facial Moisturizer With SPF 50+
All subjects received Cetaphil Daily Facial Moisturizer with SPF 50+
110
Total110

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Violation12
Overall StudyWithdrawal by Subject6

Baseline characteristics

CharacteristicFacial Moisturizer With SPF 50+
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
109 Participants
Age, Continuous44.0 years
STANDARD_DEVIATION 13.68
Race/Ethnicity, Customized
African American
10 Participants
Race/Ethnicity, Customized
Asian
3 Participants
Race/Ethnicity, Customized
Caucasian
71 Participants
Race/Ethnicity, Customized
Caucasian/Hispanic
3 Participants
Race/Ethnicity, Customized
Hispanic
23 Participants
Region of Enrollment
United States
110 participants
Sex: Female, Male
Female
86 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 110
serious
Total, serious adverse events
0 / 110

Outcome results

Primary

Area of Erythema and Elevated Responses of Skin to Product

Subjects were patched 9 times at 48 hour to 72 hour intervals and graded for erythema and elevated responses (edema, papules, vesicles, bullae) on a 4 point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). 12 to 24 hours after the last patch application, a challenge patch was applied at the same site and a challenge patch was applied to an alternate site. Both were graded for the same criteria at 48 hours and at 96 hours. A total of 11 patches were applied to each subject. All patches were removed after 48 hours.

Time frame: 3 consecutive weeks

ArmMeasureGroupValue (NUMBER)
Patch 1Area of Erythema and Elevated Responses of Skin to ProductModerate0 participants
Patch 1Area of Erythema and Elevated Responses of Skin to ProductNone91 participants
Patch 1Area of Erythema and Elevated Responses of Skin to ProductMild19 participants
Patch 2Area of Erythema and Elevated Responses of Skin to ProductModerate1 participants
Patch 2Area of Erythema and Elevated Responses of Skin to ProductMild41 participants
Patch 2Area of Erythema and Elevated Responses of Skin to ProductNone68 participants
Patch 3Area of Erythema and Elevated Responses of Skin to ProductMild72 participants
Patch 3Area of Erythema and Elevated Responses of Skin to ProductNone33 participants
Patch 3Area of Erythema and Elevated Responses of Skin to ProductModerate5 participants
Patch 4Area of Erythema and Elevated Responses of Skin to ProductNone42 participants
Patch 4Area of Erythema and Elevated Responses of Skin to ProductModerate0 participants
Patch 4Area of Erythema and Elevated Responses of Skin to ProductMild68 participants
Patch 5Area of Erythema and Elevated Responses of Skin to ProductMild69 participants
Patch 5Area of Erythema and Elevated Responses of Skin to ProductNone39 participants
Patch 5Area of Erythema and Elevated Responses of Skin to ProductModerate2 participants
Patch 6Area of Erythema and Elevated Responses of Skin to ProductModerate8 participants
Patch 6Area of Erythema and Elevated Responses of Skin to ProductNone20 participants
Patch 6Area of Erythema and Elevated Responses of Skin to ProductMild82 participants
Patch 7Area of Erythema and Elevated Responses of Skin to ProductMild72 participants
Patch 7Area of Erythema and Elevated Responses of Skin to ProductNone33 participants
Patch 7Area of Erythema and Elevated Responses of Skin to ProductModerate5 participants
Patch 8Area of Erythema and Elevated Responses of Skin to ProductNone33 participants
Patch 8Area of Erythema and Elevated Responses of Skin to ProductMild72 participants
Patch 8Area of Erythema and Elevated Responses of Skin to ProductModerate5 participants
Patch 9Area of Erythema and Elevated Responses of Skin to ProductNone23 participants
Patch 9Area of Erythema and Elevated Responses of Skin to ProductMild78 participants
Patch 9Area of Erythema and Elevated Responses of Skin to ProductModerate9 participants
Challenge Patch (Original Site) - 48 HoursArea of Erythema and Elevated Responses of Skin to ProductMild31 participants
Challenge Patch (Original Site) - 48 HoursArea of Erythema and Elevated Responses of Skin to ProductModerate1 participants
Challenge Patch (Original Site) - 48 HoursArea of Erythema and Elevated Responses of Skin to ProductNone78 participants
Challenge Patch (Original Site) - 96 HoursArea of Erythema and Elevated Responses of Skin to ProductMild24 participants
Challenge Patch (Original Site) - 96 HoursArea of Erythema and Elevated Responses of Skin to ProductNone85 participants
Challenge Patch (Original Site) - 96 HoursArea of Erythema and Elevated Responses of Skin to ProductModerate1 participants
Challenge Patch (Alternate Site) - 48 HoursArea of Erythema and Elevated Responses of Skin to ProductNone86 participants
Challenge Patch (Alternate Site) - 48 HoursArea of Erythema and Elevated Responses of Skin to ProductModerate1 participants
Challenge Patch (Alternate Site) - 48 HoursArea of Erythema and Elevated Responses of Skin to ProductMild23 participants
Challenge Patch (Alternate Site) - 96 HoursArea of Erythema and Elevated Responses of Skin to ProductModerate3 participants
Challenge Patch (Alternate Site) - 96 HoursArea of Erythema and Elevated Responses of Skin to ProductMild12 participants
Challenge Patch (Alternate Site) - 96 HoursArea of Erythema and Elevated Responses of Skin to ProductNone95 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026